trending Market Intelligence /marketintelligence/en/news-insights/trending/MJkP3msflf8UcG23126NHw2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

CohBar gets Nasdaq noncompliance notice

Blog

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Video

Climate Credit Analytics: Linking climate scenarios to financial impacts

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


CohBar gets Nasdaq noncompliance notice

CohBar Inc. fell out of compliance with the Nasdaq Capital Market's audit committee requirements for continued listing.

The company lost compliance when Philippe Calais resigned from its audit committee Dec. 6.

CohBar has until its next annual stockholder meeting, on Dec. 9, 2019, to replace Calais and regain compliance. If the company's next annual stockholder meeting is held before June 5, 2019, the deadline will be on that date.

The noncompliance notice has no immediate effect on the listing of CohBar's common stock.

Menlo Park, Calif.-based CohBar develops mitochondria-based therapeutics for diseases associated with aging and metabolic dysfunction.